Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
15,800
Stocks News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,232.60 | 65.90 | 0.81% |
| CAC 40 | 8,108.59 | 86.26 | 1.08% |
| DAX 40 | 23,109.79 | 257.13 | 1.13% |
| Dow JONES (US) | 42,587.50 | 4.18 | 0.01% |
| FTSE 100 | 8,663.80 | 25.79 | 0.30% |
| HKSE | 23,344.25 | 561.31 | -2.35% |
| NASDAQ | 18,271.86 | 83.26 | 0.46% |
| Nikkei 225 | 38,049.40 | 268.86 | 0.71% |
| NZX 50 Index | 12,322.31 | 137.80 | 1.13% |
| S&P 500 | 5,776.65 | 9.08 | 0.16% |
| S&P/ASX 200 | 8,009.30 | 66.80 | 0.84% |
| SSE Composite Index | 3,369.96 | 0.02 | -0.00% |